Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting Local Anesthetic for Post-op Opioid Reduction in Rhinoplasty
NCT04377204Phase 1Completed
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoint: Number and frequency of Pain pills taken up to 1 week post-op. Started Jun 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04377204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377204.